Brief: Incyte And CMS Announce Collaboration And License Agreement For Ruxolitinib Cream In Greater China And Southeast Asia

China Medical System Holdings

02/12/2022 13:58

Dec 2 (Reuters) - Incyte Corp  INCY.O :
    * INCYTE AND CMS ANNOUNCE COLLABORATION AND LICENSE
AGREEMENT FOR
RUXOLITINIB CREAM IN GREATER CHINA AND SOUTHEAST ASIA
    * INCYTE CORP - CMS WILL MAKE AN UPFRONT PAYMENT TO INCYTE
    * INCYTE CORP - CMS WILL RECEIVE AN EXCLUSIVE LICENSE TO
DEVELOP
AND COMMERCIALIZE AND A NON-EXCLUSIVE LICENSE TO MANUFACTURE
RUXOLITINIB CREAM
    * INCYTE-ELIGIBLE TO RECEIVE ADDITIONAL POTENTIAL
DEVELOPMENT,
REGULATORY,COMMERCIAL MILESTONES,ROYALTIES ON SALES OF LICENSED
PRODUCT IN CMS' TERRITORY
    * INCYTE CORP - TRANSACTION IS EFFECTIVE IMMEDIATELY UPON
EXECUTION OF COLLABORATION AND LICENSE AGREEMENT

Source text for Eikon:  ID:nBwccqgYWa 
Further company coverage:  INCY.O 
 ((Reuters.Briefs@thomsonreuters.com;;))